Interaction of doxycycline and warfarin: an enhanced anticoagulant effect.
OBJECTIVE
To highlight the importance of recognizing the increased anticoagulant effect of warfarin associated with use of doxycycline.


METHODS
Case report.


METHODS
Clinical review describing initial presentation, course, and outcome of one patient who received oral doxycycline for corneal melt while on warfarin in a multi-specialty clinic.


RESULTS
Concomitant use of doxycycline and warfarin resulted in prominent ecchymosis of the upper extremities associated with a marked elevation in the international normalized ratio (INR = 6.5). Discontinuation of doxycycline resulted in reduction of INR to therapeutic levels (INR = 2.3).


CONCLUSIONS
Doxycycline can enhance the anticoagulant effect of warfarin. This is likely due to competitive interaction for albumin binding and possibly inhibition of the cytochrome P-450 system. An increase in plasma levels of free warfarin may result in severe bleeding. It is important to recognize this potential interaction and obtain a complete medication profile prior to initiating doxycycline.
Hasan
Saiyid Akbar
SA
Mayo Clinic, Jacksonville, FL 32224, USA. Hasan.saiyid@mayo.edu
D000284:Administration, Oral; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D003320:Corneal Ulcer / Q000188:drug therapy; D004318:Doxycycline / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004438:Ecchymosis / Q000139:chemically induced*; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D014859:Warfarin; D004318:Doxycycline